Life Science Nation (LSN), MaRS, and Johnson and Johnson Innovation, JLABS have partnered for the second time to bring the Redefining Early Stage Investments (RESI) Conference to Toronto on April 4th, 2017. RESI on MaRS will bring together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.
The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The recent RESI Conference in San Francisco had nearly 1000 registrants and a full partnering floor. Through the RESI Partnering, fundraising executives can have up to 16 scheduled meetings as well as many more ad-hoc meetings with diverse life science investors who fit their company’s technology sector, indication and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.
RESI will be at the MaRS Centre, the home of notable life science organizations including JLABS@Toronto, the Ontario Institute for Cancer Research, Synaptive Medical, and LEAGUE.